Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Bionic 'Super Lenses' Could Correct Vision Deterioration

By HospiMedica International staff writers
Posted on 22 Sep 2008
Bionic ocular implants that correct both long and shortsightedness, allowing patients to throw away their glasses for good, could be available in as little as five years.

Researchers at Aston University (Birmingham, United Kingdom) are developing so-called "bionic surgery” which promises treatment of both long and shortsightedness. More...
The new implantable intraocular lens (IOL), which is attached to the muscles of the eye, would be extra-flexible, allowing it to be formed into a different shape by the eye's muscles, so that the eye can focus on both near and distant objects, and all points in between (a process known as accommodation). The new surgery is also claimed to prevent future cataracts in those implanted with the lens, since the IOL replaces the natural, biological lens. The surgical procedure is similar to cataract surgery.

"As you get older, the lens of your eye hardens and is no longer able to change its shape and focus, so you have to hold something further away to read it; by 45, you can no longer stretch your arms far enough and you need glasses,” said lead investigator optometrist Professor James Wolffsohn, Ph.D. "Everyone over 45 would benefit because it means they will be able to see distance and near absolutely naturally. It is the true definition of a bionic eye. You are replacing something that has aged in the eye with a technological structure.”

While using an IOL implant to correct vision clouded by a cataract or presbyopia is similar to the new lens being developed, there is no accommodation. The eye's natural lens is replaced by either a monofocal intraocular lens (used to give clear point focus either at a distance or close up), or multifocal IOLs, which allow correction of vision at all distances. However, in both cases, deterioration in vision requires repeat intraocular surgery and replacement of the lens. The new lens would be a permanent implant.

Related Links:
Aston University



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.